FDA approves Roche’s Enspryng as first at-home injection treatment for thyroid eye disease

The approval was supported by data from Roche’s pivotal Phase III SatraGO programme
This is a short summary. The full story is published by Indianpharmapost.
Read full story at Indianpharmapost

